Schalken, J., & Fitzpatrick, J. M. (2015). Enzalutamide: Targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer. BJU Int.
Chicago Style aipamenaSchalken, Jack, and John M. Fitzpatrick. "Enzalutamide: Targeting the Androgen Signalling Pathway in Metastatic Castration‐resistant Prostate Cancer." BJU Int 2015.
MLA aipamenaSchalken, Jack, and John M. Fitzpatrick. "Enzalutamide: Targeting the Androgen Signalling Pathway in Metastatic Castration‐resistant Prostate Cancer." BJU Int 2015.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.